Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes (Details)

v3.26.1
Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Taxes [Line Items]    
Income taxes paid
Valuation allowance 116,077 101,613
Federal research and development tax credits 20,131 $ 20,664
Net operating losses $ 104,800  
Tax Jurisdiction of Domicile [Extensible Enumeration] federal  
Indefinite life $ 114,600  
Net operating loss percentage 80.00%  
Unused net operating losses $ 204,600  
Minimum [Member]    
Income Taxes [Line Items]    
Valuation allowance 116,100  
Maximum [Member]    
Income Taxes [Line Items]    
Valuation allowance 14,500  
Federal Research and Development [Member]    
Income Taxes [Line Items]    
Federal research and development tax credits 218,900  
Foreign NOL [Member]    
Income Taxes [Line Items]    
Net operating losses 48  
Orphan Drug Credit [Member]    
Income Taxes [Line Items]    
Federal research and development tax credits 24,800  
Expire in 2026 [Member]    
Income Taxes [Line Items]    
Net operating losses 3,600  
Net operating losses expire in 2034 - 2037 [Member]    
Income Taxes [Line Items]    
Net operating losses 15,000  
Tax Year 2033 [Member]    
Income Taxes [Line Items]    
Federal research and development tax credits 8,100  
Tax Year 2037 [Member] | Orphan Drug Credit [Member]    
Income Taxes [Line Items]    
Federal research and development tax credits $ 16,700